Facial fat necrosis after autologous fat transfer possibly associated with SARS-CoV-2 vaccine

J Cosmet Dermatol. 2023 May;22(5):1477-1480. doi: 10.1111/jocd.15635. Epub 2023 Mar 9.

Abstract

A 52-year-old female patient developed facial fat necrosis presenting with cutaneous induration three weeks after minimal access cranial suspension (MACS) lift with autologous fat grafting from the abdomen. Given that the patient received the Moderna SARS-CoV-2 vaccine one week after surgery, we hypothesize that the former predisposed her to tissue ischemia leading to fat necrosis. Histological findings after biopsy were consistent with fat necrosis, which included marked dermal fibrosis with areas of focal fat necrosis, lipophages, multinucleated giant cells, and siderophages. It is our hope that documenting this rare development in literature may serve as encouragement for adverse effect reporting after the SARS-CoV-2 vaccine administration and may boost inspection and monitoring of other health consequences by regulating agencies.

Keywords: COVID-19 vaccine; SARS-CoV-2 vaccine; autologous fat transfer; cutaneous induration; fat necrosis; flap necrosis.

Publication types

  • Case Reports

MeSH terms

  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Face
  • Fat Necrosis*
  • Female
  • Humans
  • Middle Aged
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines